Expression of Epstein-Barr Virus Membrane Antigen gp340/220 in Mouse Fibroblasts Using a Bovine Papillomavirus Vector
- 1 March 1989
- journal article
- research article
- Published by Microbiology Society in Journal of General Virology
- Vol. 70 (3) , 729-734
- https://doi.org/10.1099/0022-1317-70-3-729
Abstract
Summary Epstein-Barr virus (EBV) membrane antigen glycoproteins gp340 and gp220 are encoded by a single gene. We have inserted this gene into a bovine papillomavirus (BPV) vector and expressed gp340/220 in mammalian cells under the control of the mouse metallothionein promoter. The proteins produced were of similar M r, showed similar antigenic specificity and were transported to the same subcellular location as the authentic gp340/220. The inclusion of heavy metal ions in the medium had no effect on the levels of gp340/220, which were approximately the same as those found in standard EBV-transformed lymphoblastoid cell lines, e.g. B95-8. Cells that expressed gp340/220 were selected by several rounds of fluorescence-activated cell sorting, but on passage they rapidly lost the ability to express this glycoprotein. In contrast to this we found that BPV-transformed cells expressing a truncated version of gp340/220 still produced it at significant levels after extended passage.Keywords
This publication has 16 references indexed in Scilit:
- Recombinant vaccinia virus induces neutralising antibodies in rabbits against Epstein-Barr virus membrane antigen gp340.The EMBO Journal, 1985
- Lines of BPV-transformed murine cells that constitutively express influenza virus hemagglutinin.The EMBO Journal, 1985
- Transcription and DNA sequence of the BamHI L fragment of B95-8 Epstein-Barr virus.The EMBO Journal, 1984
- An Epstein-Barr virus DNA fragment encodes messages for the two major envelope glycoproteins (gp350/300 and gp220/200)Journal of Virology, 1984
- Mesophyll resistance to photosynthetic carbon dioxide uptake in leaves: dependence upon stomatal apertureCanadian Journal of Botany, 1984
- Identification and isolation of the main component (gp350-gp220) of Epstein-Barr virus responsible for generating neutralizing antibodies in vivoJournal of Virology, 1982
- Monoclonal antibodies against the major glycoprotein (gp350/220) of Epstein-Barr virus neutralize infectivity.Proceedings of the National Academy of Sciences, 1980
- Monoclonal antibody against a 250,000-dalton glycoprotein of Epstein-Barr virus identifies a membrane antigen and a neutralizing antigen.Proceedings of the National Academy of Sciences, 1980
- Epidemiological evidence for causal relationship between Epstein-Barr virus and Burkitt's lymphoma from Ugandan prospective studyNature, 1978
- Epstein-Barr Virus — Is It Time To Develop a Vaccine Program?JNCI Journal of the National Cancer Institute, 1976